Followers | 20 |
Posts | 2394 |
Boards Moderated | 0 |
Alias Born | 01/28/2012 |
Friday, February 01, 2013 2:12:05 PM
http://www.stockpickr.com/5-stocks-poised-breakouts.html-23?puc=yahoo&cm_ven=YAHOO
Apricus Biosciences
My final idea today for a near-term breakout trade is Apricus Biosciences (APRI), which is a hybrid specialty pharmaceutical company in the areas of oncology, sexual dysfunction, autoimmune and anti-infectives, among others. This stock has been ripping higher so far in 2013, with shares up an impressive 42.7%.
If you look at the chart for Apricus Biosciences, you’ll notice that this stock has been uptrending strong for the last month, with shares spiking higher from its low of $1.95 to its recent high of $2.97 a share. During that uptrend, shares of APRI have been consistently making higher lows and higher highs, which is bullish technical price action. That move has just started to push shares of APRI back above its 200-day moving average of $2.77 and it’s quickly pushing the stock within range of triggering a near-term breakout trade.
Traders should now look for long-biased trades in APRI once it manages to take out some near-term overhead resistance levels at $2.97 to $3.18 a share with high volume. Look for a sustained move or close above those levels with volume that registers near or above its three-month average volume of 144,045 shares. If that breakout triggers soon, then APRI will set up to re-test or possibly take out its next major overhead resistance levels at $3.45 to $3.48 a share and at $3.51 to $3.67 a share. Any high-volume move above $4 a share will then give APRI a chance to re-fill some of its previous gap down zone from last February that started at around $5 a share.
One could look to buy APRI off any weakness to anticipate that breakout and then simply use a stop that sits right around some key near-term support levels at $2.50 to $2.40 a share. Traders can also look to buy APRI off strength once it takes out those breakout levels with volume and then simply use a stop that sits right below its 200-day moving average of $2.19 a share.
This is another stock with short-squeeze potential off that breakout, since the current short interest as a percentage of the float for APRI is pretty high at 10%. Look for a solid short-covering rally to ensue if APRI triggers that breakout soon.
Recent SEEL News
- Form 8-K - Current report • Edgar (US Regulatory) • 10/15/2024 01:15:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/07/2024 10:07:04 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 09/26/2024 08:15:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/26/2024 08:10:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/25/2024 12:53:01 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 09/25/2024 10:09:32 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/24/2024 08:05:35 PM
- Biotech Soars On Material Transfer Agreement • AllPennyStocks.com • 09/24/2024 07:10:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/03/2024 01:00:17 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 08/26/2024 04:15:16 AM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 08/20/2024 08:01:49 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 08/16/2024 08:02:17 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:05:46 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 08/09/2024 08:02:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 08:06:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/26/2024 08:01:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/16/2024 08:05:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/12/2024 01:15:52 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 06/14/2024 08:06:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 08:05:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/21/2024 08:01:36 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/20/2024 08:16:07 PM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM